{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:09:20Z","timestamp":1790874560754,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T00:00:00Z","timestamp":1662336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T00:00:00Z","timestamp":1662336000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Young Scholars Fostering Fund of the First Affiliated Hospital of Nanjing Medical University","award":["PY2021036"],"award-info":[{"award-number":["PY2021036"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81770166"],"award-info":[{"award-number":["81770166"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81720108002"],"award-info":[{"award-number":["81720108002"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82170185"],"award-info":[{"award-number":["82170185"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"CSCO Research Foundation","award":["Y-Roche2019\/2-0090"],"award-info":[{"award-number":["Y-Roche2019\/2-0090"]}]},{"name":"Translational research grant of NCRCH","award":["2020ZKZB01"],"award-info":[{"award-number":["2020ZKZB01"]}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20211376"],"award-info":[{"award-number":["BK20211376"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Hematol Oncol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>Circular RNAs (circRNAs) play a critical role in the modulation of tumor metabolism. However, the expression patterns and metabolic function of circRNAs in chronic lymphocytic leukemia (CLL) remain largely unknown. This study aimed to elucidate the role of circRNAs in the lipid metabolism of CLL.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The expression and metabolic patterns of circRNAs in a cohort of 53 patients with CLL were investigated using whole transcriptome sequencing. Cell viability, liquid chromatography with tandem mass spectrometry (LC\u2013MS\/MS) analysis, lipid analysis, Nile red staining as well as triglyceride (TG) assay were used to evaluate the biological function of circRIC8B in CLL. The regulatory mechanisms of circRIC8B\/miR-199b-5p\/lipoprotein lipase (LPL) axis were explored by luciferase assay, RNA immunoprecipitation (RIP), qRT-PCR, and fluorescence in situ hybridization (FISH). CCK-8 and flow cytometry were used to verify the inhibition role of cholesterol absorption inhibitor, ezetimibe, in CLL cells.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Increased circRIC8B expression was positively correlated with advanced progression and poor prognosis. Knockdown of circRIC8B significantly suppressed the proliferation and lipid accumulation of CLL cells. In contrast, the upregulation of circRIC8B exerted opposite effects. Mechanistically, circRIC8B acted as a sponge of miR-199b-5p and prevented it from decreasing the level of LPL mRNA, and this promotes lipid metabolism alteration and facilitates the progression of CLL. What\u2019s more, ezetimibe suppressed the expression of LPL mRNA and inhibited the growth of CLL cells.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>In this study, the expressional and metabolic patterns of circRNAs in CLL was illustrated for the 1st\u00a0time. Our findings revealed that circRIC8B regulates the lipid metabolism abnormalities in and development of CLL through the miR-199b-5p\/LPL axis. CircRIC8B may serve as a promising prognostic marker and therapeutic target, which enhances the sensitivity to ezetimibe in CLL.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40164-022-00302-0","type":"journal-article","created":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T08:05:05Z","timestamp":1662365105000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["CircRIC8B regulates the lipid metabolism of chronic lymphocytic leukemia through miR199b-5p\/LPL axis"],"prefix":"10.1186","volume":"11","author":[{"given":"Zijuan","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danling","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huayuan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luqiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueying","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuchao","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianyong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,5]]},"reference":[{"key":"302_CR1","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.leukres.2018.08.011","volume":"73","author":"S Yang","year":"2018","unstructured":"Yang S, Gale RP, Shi H, Liu Y, Lai Y, Lu J, et al. Is there an epidemic of chronic lymphocytic leukaemia (CLL) in China? Leuk Res. 2018;73:16\u201320.","journal-title":"Leuk Res"},{"issue":"1","key":"302_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics. Cancer J Clin. 2020;70(1):7\u201330.","journal-title":"Cancer J Clin"},{"key":"302_CR3","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40164-020-00170-6","volume":"9","author":"Y Dong","year":"2020","unstructured":"Dong Y, Shi O, Zeng Q, Lu X, Wang W, Li Y, et al. Leukemia incidence trends at the global, regional, and national level between 1990 and 2017. Exp Hematol Oncol. 2020;9:14.","journal-title":"Exp Hematol Oncol"},{"issue":"3","key":"302_CR4","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/nrc.2016.8","volume":"16","author":"G Fabbri","year":"2016","unstructured":"Fabbri G, Dalla-Favera R. The molecular pathogenesis of chronic lymphocytic leukaemia. Nat Rev Cancer. 2016;16(3):145\u201362.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"302_CR5","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.cell.2016.12.039","volume":"168","author":"MG Vander Heiden","year":"2017","unstructured":"Vander Heiden MG, DeBerardinis RJ. Understanding the Intersections between metabolism and cancer biology. Cell. 2017;168(4):657\u201369.","journal-title":"Cell"},{"issue":"2","key":"302_CR6","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s00018-015-2070-4","volume":"73","author":"Z Li","year":"2016","unstructured":"Li Z, Zhang H. Reprogramming of glucose, fatty acid and amino acid metabolism for cancer progression. Cell Mol Life Sci CMLS. 2016;73(2):377\u201392.","journal-title":"Cell Mol Life Sci CMLS"},{"issue":"4","key":"302_CR7","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/s41585-020-0288-x","volume":"17","author":"DA Bader","year":"2020","unstructured":"Bader DA, McGuire SE. Tumour metabolism and its unique properties in prostate adenocarcinoma. Nat Rev Urol. 2020;17(4):214\u201331.","journal-title":"Nat Rev Urol"},{"issue":"7","key":"302_CR8","doi-asserted-by":"publisher","first-page":"4797","DOI":"10.1002\/jcp.30200","volume":"236","author":"G Yu","year":"2021","unstructured":"Yu G, Yang Z, Peng T, Lv Y. Circular RNAs: Rising stars in lipid metabolism and lipid disorders. J Cell Physiol. 2021;236(7):4797\u2013806.","journal-title":"J Cell Physiol"},{"issue":"1","key":"302_CR9","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.cmet.2019.05.009","volume":"30","author":"Q Li","year":"2019","unstructured":"Li Q, Wang Y, Wu S, Zhou Z, Ding X, Shi R, et al. CircACC1 regulates assembly and activation of AMPK complex under metabolic stress. Cell Metab. 2019;30(1):157-73.e7.","journal-title":"Cell Metab"},{"issue":"1","key":"302_CR10","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.cell.2020.08.009","volume":"183","author":"Q Zhao","year":"2020","unstructured":"Zhao Q, Liu J, Deng H, Ma R, Liao JY, Liang H, et al. Targeting mitochondria-located circRNA SCAR alleviates NASH via reducing mROS output. Cell. 2020;183(1):76-93.e22.","journal-title":"Cell"},{"issue":"6","key":"302_CR11","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1038\/sj.leu.2404220","volume":"20","author":"M Bilban","year":"2006","unstructured":"Bilban M, Heintel D, Scharl T, Woelfel T, Auer MM, Porpaczy E, et al. Deregulated expression of fat and muscle genes in B-cell chronic lymphocytic leukemia with high lipoprotein lipase expression. Leukemia. 2006;20(6):1080\u20138.","journal-title":"Leukemia"},{"issue":"6","key":"302_CR12","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1517\/14728222.10.6.851","volume":"10","author":"IF Gazi","year":"2006","unstructured":"Gazi IF, Mikhailidis DP. Non-low-density lipoprotein cholesterol-associated actions of ezetimibe: an overview. Expert Opin Ther Targets. 2006;10(6):851\u201366.","journal-title":"Expert Opin Ther Targets"},{"issue":"7","key":"302_CR13","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1038\/sj.leu.2403748","volume":"19","author":"D Heintel","year":"2005","unstructured":"Heintel D, Kienle D, Shehata M, Kr\u00f6ber A, Kroemer E, Schwarzinger I, et al. High expression of lipoprotein lipase in poor risk B-cell chronic lymphocytic leukemia. Leukemia. 2005;19(7):1216\u201323.","journal-title":"Leukemia"},{"issue":"4","key":"302_CR14","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/S0022-2275(20)37569-6","volume":"37","author":"IJ Goldberg","year":"1996","unstructured":"Goldberg IJ. Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. J Lipid Res. 1996;37(4):693\u2013707.","journal-title":"J Lipid Res"},{"issue":"3","key":"302_CR15","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1038\/s41375-019-0594-6","volume":"34","author":"Z Wu","year":"2020","unstructured":"Wu Z, Sun H, Liu W, Zhu H, Fu J, Yang C, et al. Circ-RPL15: a plasma circular RNA as novel oncogenic driver to promote progression of chronic lymphocytic leukemia. Leukemia. 2020;34(3):919\u201323.","journal-title":"Leukemia"},{"key":"302_CR16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics. 2013;14:7.","journal-title":"BMC Bioinformatics"},{"issue":"7574","key":"302_CR17","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/nature15395","volume":"526","author":"DA Landau","year":"2015","unstructured":"Landau DA, Tausch E, Taylor-Weiner AN, Stewart C, Reiter JG, Bahlo J, et al. Mutations driving CLL and their evolution in progression and relapse. Nature. 2015;526(7574):525\u201330.","journal-title":"Nature"},{"issue":"5","key":"302_CR18","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.1600200","volume":"2","author":"RJ DeBerardinis","year":"2016","unstructured":"DeBerardinis RJ, Chandel NS. Fundamentals of cancer metabolism. Sci Adv. 2016;2(5): e1600200.","journal-title":"Sci Adv"},{"issue":"4","key":"302_CR19","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/ncb3124","volume":"17","author":"LK Boroughs","year":"2015","unstructured":"Boroughs LK, DeBerardinis RJ. Metabolic pathways promoting cancer cell survival and growth. Nat Cell Biol. 2015;17(4):351\u20139.","journal-title":"Nat Cell Biol"},{"issue":"3","key":"302_CR20","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.beha.2007.03.007","volume":"20","author":"N Chiorazzi","year":"2007","unstructured":"Chiorazzi N. Cell proliferation and death: forgotten features of chronic lymphocytic leukemia B cells. Best Pract Res Clin Haematol. 2007;20(3):399\u2013413.","journal-title":"Best Pract Res Clin Haematol"},{"issue":"4","key":"302_CR21","doi-asserted-by":"publisher","first-page":"758","DOI":"10.3109\/10428194.2015.1106533","volume":"57","author":"U Rozovski","year":"2016","unstructured":"Rozovski U, Hazan-Halevy I, Barzilai M, Keating MJ, Estrov Z. Metabolism pathways in chronic lymphocytic leukemia. Leuk Lymphoma. 2016;57(4):758\u201365.","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"302_CR22","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s13045-020-00976-1","volume":"13","author":"X Zhou","year":"2020","unstructured":"Zhou X, Zhan L, Huang K, Wang X. The functions and clinical significance of circRNAs in hematological malignancies. J Hematol Oncol. 2020;13(1):138.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"302_CR23","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13045-019-0776-8","volume":"12","author":"T Yu","year":"2019","unstructured":"Yu T, Wang Y, Fan Y, Fang N, Wang T, Xu T, et al. CircRNAs in cancer metabolism: a review. J Hematol Oncol. 2019;12(1):90.","journal-title":"J Hematol Oncol"},{"issue":"6","key":"302_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107641","volume":"31","author":"G Di Timoteo","year":"2020","unstructured":"Di Timoteo G, Dattilo D, Centr\u00f3n-Broco A, Colantoni A, Guarnacci M, Rossi F, et al. Modulation of circRNA Metabolism by m(6)A Modification. Cell Rep. 2020;31(6): 107641.","journal-title":"Cell Rep"},{"key":"302_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2020.144720","volume":"749","author":"B Jamalzei","year":"2020","unstructured":"Jamalzei B, Karami Tehrani FS, Atri M. Evaluation of LDL receptor and Scavenger receptor, Class B, Type 1 in the malignant and benign breast tumors: the correlation with the expression of miR-199a-5p, miR-199b-5p and miR-455-5p. Gene. 2020;749: 144720.","journal-title":"Gene"},{"key":"302_CR26","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.omtn.2020.04.017","volume":"20","author":"Z Wu","year":"2020","unstructured":"Wu Z, Sun H, Wang C, Liu W, Liu M, Zhu Y, et al. Mitochondrial genome-derived circRNA mc-COX2 functions as an oncogene in chronic lymphocytic leukemia. Mol Therapy Nucleic acids. 2020;20:801\u201311.","journal-title":"Mol Therapy Nucleic acids"},{"issue":"11","key":"302_CR27","doi-asserted-by":"publisher","first-page":"3561","DOI":"10.18632\/aging.101997","volume":"11","author":"W Wu","year":"2019","unstructured":"Wu W, Wu Z, Xia Y, Qin S, Li Y, Wu J, et al. Downregulation of circ_0132266 in chronic lymphocytic leukemia promoted cell viability through miR-337-3p\/PML axis. Aging. 2019;11(11):3561\u201373.","journal-title":"Aging"},{"key":"302_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/ph14020168","author":"MF Lingua","year":"2021","unstructured":"Lingua MF, Carr\u00e0 G, Maffeo B, Morotti A. Non-Coding RNAs: The \u201cDark Side Matter\u201d of the CLL Universe. Pharmaceuticals. 2021. https:\/\/doi.org\/10.3390\/ph14020168.","journal-title":"Pharmaceuticals"},{"issue":"1","key":"302_CR29","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12943-020-01169-7","volume":"19","author":"C Qin","year":"2020","unstructured":"Qin C, Yang G, Yang J, Ren B, Wang H, Chen G, et al. Metabolism of pancreatic cancer: paving the way to better anticancer strategies. Mol Cancer. 2020;19(1):50.","journal-title":"Mol Cancer"},{"issue":"4","key":"302_CR30","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1158\/0008-5472.CAN-20-1323","volume":"81","author":"LY Cai","year":"2021","unstructured":"Cai LY, Chen SJ, Xiao SH, Sun QJ, Ding CH, Zheng BN, et al. Targeting p300\/CBP attenuates hepatocellular carcinoma progression through epigenetic regulation of metabolism. Can Res. 2021;81(4):860\u201372.","journal-title":"Can Res"},{"issue":"7838","key":"302_CR31","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/s41586-020-2928-y","volume":"588","author":"XY Lu","year":"2020","unstructured":"Lu XY, Shi XJ, Hu A, Wang JQ, Ding Y, Jiang W, et al. Feeding induces cholesterol biosynthesis via the mTORC1-USP20-HMGCR axis. Nature. 2020;588(7838):479\u201384.","journal-title":"Nature"},{"issue":"1","key":"302_CR32","first-page":"11","volume":"105","author":"W Masson","year":"2015","unstructured":"Masson W, Siniawski D, Lobo M, Molinero G, Giorgi M, Huer\u00edn M. Association between LDL-C, Non HDL-C, and Apolipoprotein B Levels with coronary plaque regression. Arq Bras Cardiol. 2015;105(1):11\u20139.","journal-title":"Arq Bras Cardiol"},{"issue":"8","key":"302_CR33","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1177\/0003319717748771","volume":"69","author":"T Lin","year":"2018","unstructured":"Lin T, Wang L, Guo J, Liu P, Chen L, Wei M, et al. Association between serum LDL-C and ApoB and SYNTAX score in patients with stable coronary artery disease. Angiology. 2018;69(8):724\u20139.","journal-title":"Angiology"},{"issue":"4","key":"302_CR34","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s40256-020-00421-1","volume":"20","author":"YN Lamb","year":"2020","unstructured":"Lamb YN. Rosuvastatin\/Ezetimibe: a review in hypercholesterolemia. Am J Cardiovasc Drugs. 2020;20(4):381\u201392.","journal-title":"Am J Cardiovasc Drugs"},{"issue":"18","key":"302_CR35","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1001\/jama.2014.4030","volume":"311","author":"JG Robinson","year":"2014","unstructured":"Robinson JG, Nedergaard BS, Rogers WJ, Fialkow J, Neutel JM, Ramstad D, et al. Effect of evolocumab or ezetimibe added to moderate- or high-intensity statin therapy on LDL-C lowering in patients with hypercholesterolemia: the LAPLACE-2 randomized clinical trial. JAMA. 2014;311(18):1870\u201382.","journal-title":"JAMA"},{"issue":"4","key":"302_CR36","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/j.1365-2184.2011.00758.x","volume":"44","author":"MF Mulas","year":"2011","unstructured":"Mulas MF, Abete C, Pulisci D, Pani A, Massidda B, Dess\u00ec S, et al. Cholesterol esters as growth regulators of lymphocytic leukaemia cells. Cell Prolif. 2011;44(4):360\u201371.","journal-title":"Cell Prolif"},{"key":"302_CR37","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ebiom.2016.11.033","volume":"15","author":"L McCaw","year":"2017","unstructured":"McCaw L, Shi Y, Wang G, Li YJ, Spaner DE. Low density lipoproteins amplify cytokine-signaling in chronic lymphocytic leukemia cells. EBioMedicine. 2017;15:24\u201335.","journal-title":"EBioMedicine"}],"container-title":["Experimental Hematology &amp; Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40164-022-00302-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40164-022-00302-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40164-022-00302-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T08:10:28Z","timestamp":1662365428000},"score":1,"resource":{"primary":{"URL":"https:\/\/ehoonline.biomedcentral.com\/articles\/10.1186\/s40164-022-00302-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,5]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["302"],"URL":"https:\/\/doi.org\/10.1186\/s40164-022-00302-0","relation":{},"ISSN":["2162-3619"],"issn-type":[{"value":"2162-3619","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,5]]},"assertion":[{"value":"31 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was authorized by the Ethics Committee of Jiangsu Province Hospital. All patients signed consent forms.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"51"}}